Wall Street is positive on Aytu Bioscience Inc (AYTU). On average, analysts give Aytu Bioscience Inc a Strong Buy rating. The average price target is $23.75, which means analysts expect the stock to increase by 275.20% over the next twelve months.
That average ranking earns Aytu Bioscience Inc an Analyst Rating of 79, which is better than 79% of stocks based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.
InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.
What's Happening With Aytu Bioscience Inc Stock Today?
Aytu Bioscience Inc (AYTU) stock is trading at $6.33 as of 9:59 AM on Wednesday, Dec 16, a gain of $0.28, or 4.72% from the previous closing price of $6.04. The stock has traded between $6.27 and $6.39 so far today. Volume today is low. So far 372,436 shares have traded compared to average volume of 954,152 shares.